HomeIMMX • NASDAQ
add
Immix Biopharma Inc
Previous close
$3.07
Day range
$2.86 - $3.24
Year range
$1.34 - $3.24
Market cap
103.88M USD
Avg Volume
400.08K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
The Globe and Mail
4 hours ago
VIQ Solutions Transitions to TSX Venture Exchange for Cost Optimization
0.00%
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.72M | 42.85% |
Net income | -6.62M | -50.75% |
Net profit margin | — | — |
Earnings per share | -0.22 | -46.67% |
EBITDA | -6.66M | -41.73% |
Effective tax rate | -0.13% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 11.64M | -51.46% |
Total assets | 15.64M | -45.78% |
Total liabilities | 10.98M | 122.10% |
Total equity | 4.65M | — |
Shares outstanding | 28.83M | — |
Price to book | 19.19 | — |
Return on assets | -94.54% | — |
Return on capital | -205.46% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -6.62M | -50.75% |
Cash from operations | -5.31M | -1.02% |
Cash from investing | -127.63K | -31.48% |
Cash from financing | 1.11M | — |
Net change in cash | -4.28M | 19.85% |
Free cash flow | -2.91M | 31.45% |
About
Founded
2012
Headquarters
Website
Employees
18
